Brilinta
Showing 1 - 25 of 125
Healthy Individuals Trial in Karachi (Anplag (Ticagrelor 90 mg), Brilinta (Ticagrelor 90 mg))
Completed
- Healthy Individuals
- Anplag (Ticagrelor 90 mg)
- Brilinta (Ticagrelor 90 mg)
-
Karachi, Sindh, PakistanCenter for Bioequivalence Studies and clinical research
Sep 5, 2022
Diabetes, Type 2, Coronary Artery Disease Trial in Jacksonville (Ticagrelor monotherapy, Ticagrelor plus aspirin, Clopidogrel
Recruiting
- Diabetes Mellitus, Type 2
- Coronary Artery Disease
- Ticagrelor monotherapy
- +2 more
-
Jacksonville, FloridaUniversity of Florida
May 31, 2022
Coronary Artery Disease, Myocardial Infarction Trial in Ottawa (Active Comparator: Dual Antiplatelet Therapy (DAPT) - Aspirin 81
Suspended
- Coronary Artery Disease
- Myocardial Infarction
- Active Comparator: Dual Antiplatelet Therapy (DAPT) - Aspirin 81 mg + Ticagrelor 60mg twice daily
- +2 more
-
Ottawa, Ontario, CanadaUniversity of Ottawa Heart Institute
Feb 17, 2022
Coronary Heart Disease Trial in Beijing (Ticagrelor, Clopidogrel, Aspirin)
Not yet recruiting
- Coronary Heart Disease
- Ticagrelor
- +2 more
-
Beijing, Beijing, ChinaFuwai Hospital
Oct 15, 2023
Acute Myocardial Infarction, Ticagrelor Trial in Busan (Clopidogrel 75 mg, Ticagrelor 60mg, Ticagrelor 45 mg)
Recruiting
- Acute Myocardial Infarction
- Ticagrelor
- Clopidogrel 75 mg
- +2 more
-
Busan, Korea, Republic ofDongA University Hospital
Jan 14, 2022
Chronic Kidney Diseases, Heart Attack, Stroke, Ischemic Trial in Little Rock (Ticagrelor 90mg, Clopidogrel 75mg, Aspirin 81 mg)
Completed
- Chronic Kidney Diseases
- +2 more
- Ticagrelor 90mg
- +2 more
-
Little Rock, Arkansas
- +1 more
Dec 8, 2022
Coronary Artery Disease Trial in Jacksonville (Ticagrelor 60mg, Clopidogrel)
Recruiting
- Coronary Artery Disease
- Ticagrelor 60mg
- Clopidogrel
-
Jacksonville, FloridaUniversity of Florida
Jul 6, 2022
Myocardial Infarction, Thrombosis, Platelet Dysfunction Trial in Lancaster (Clopidogrel, Ticagrelor)
Recruiting
- Myocardial Infarction
- +2 more
-
Lancaster, PennsylvaniaAmish Research Clinic
Jan 24, 2022
Anti-platelet Drug Exposure on Platelet mRNA Splicing in Healthy
Withdrawn
- Thrombosis; Artery
- Ticagrelor Oral Tablet [Brilinta]
-
Washington, District of Columbia
- +1 more
Oct 21, 2021
End Stage Renal Disease, Vascular Access Patency Trial in Charlottesville (ticagrelor, Placebo)
Completed
- End Stage Renal Disease
- Vascular Access Patency
- ticagrelor
- Placebo
-
Charlottesville, VirginiaUniversity of Virginia - Hospital West Kidney Center Dialysis
May 13, 2022
Stroke, Stroke, Ischemic, Atherosclerosis Trial in Paris (Colchicine 0.5 MG, Ticagrelor 90mg, Aspirin 75-300mg)
Not yet recruiting
- Stroke
- +7 more
- Colchicine 0.5 MG
- +2 more
-
Paris, FranceURC Lariboisière-Fernand Widal-Saint Louis
Aug 2, 2022
Percutaneous Coronary Intervention Trial in Milwaukee (Ticagrelor)
Active, not recruiting
- Percutaneous Coronary Intervention
-
Milwaukee, WisconsinAurora Health Care, St. Luke's Medical Center
May 19, 2021
Antiphospholipid Syndrome, Arterial Thrombosis Trial in Buenos Aires, Córdoba, Hamilton (Dual antiplatelet therapy, Combined
Recruiting
- Antiphospholipid Syndrome
- Arterial Thrombosis
- Dual antiplatelet therapy
- +3 more
-
Buenos Aires, Ciudad Autónoma De Buenos Aires, Argentina
- +2 more
Dec 12, 2022
Multi Vessel Coronary Artery Disease Trial in Seoul (Ticagrelor, Clopidogrel)
Not yet recruiting
- Multi Vessel Coronary Artery Disease
-
Seoul, Korea, Republic ofSeverance Hospital, Yonsei University Health System
Dec 20, 2021
Thrombosis, Myocardial Infarction Trial (Rivaroxaban, Ticagrelor)
Not yet recruiting
- Thrombosis
- Myocardial Infarction
- (no location specified)
Nov 2, 2021
Coronary Artery Disease, Diabetes Trial in Jacksonville (ticagrelor)
Completed
- Coronary Artery Disease
- Diabetes Mellitus
-
Jacksonville, FloridaUniversity of Florida
Jan 26, 2022
Coronary Artery Disease, Healthy Participants Trial in Edinburgh (Ticagrelor, BMS-986141, Aspirin)
Recruiting
- Coronary Artery Disease
- Healthy Participants
- Ticagrelor
- +2 more
-
Edinburgh, United KingdomLocal Institution - 0001
May 3, 2022
Coronary Artery Disease Trial in Nanjing (Ticagrelor, Clopidogrel)
Withdrawn
- Coronary Artery Disease
-
Nanjing, Jiangsu, ChinaNanjing First Hospital
Aug 18, 2021
Coronary Artery Disease, Atherosclerosis, Stent Placement Trial in Scottsdale, Boston, New York (Dual Antiplatelet (DAPT)
Active, not recruiting
- Coronary Artery Disease
- +2 more
- Dual Antiplatelet (DAPT) Therapy
- The Synergy® stent
-
Scottsdale, Arizona
- +2 more
Feb 15, 2022
Acute Myocardial Infarction Trial in Busan (Ticagrelor 90mg, Ticagrelor 60/45mg)
Recruiting
- Acute Myocardial Infarction
- Ticagrelor 90mg
- Ticagrelor 60/45mg
-
Busan, Korea, Republic ofDongA University Hospital
Feb 11, 2021
Diabetes, Type 2, Coronary Artery Disease Trial in Jacksonville (Ticagrelor, Clopidogrel)
Completed
- Diabetes Mellitus, Type 2
- Coronary Artery Disease
-
Jacksonville, FloridaUniversity of Florida
Nov 2, 2021
Peripheral Arterial Disease Trial in Cleveland (Ticagrelor, Clopidogrel)
Terminated
- Peripheral Arterial Disease
-
Cleveland, OhioCleveland Clinic
Jun 15, 2021
Hepatic Artery Thrombosis, Liver Transplant; Complications, Pediatric Disease Trial in Shanghai (Ticagrelor Oral Tablet
Not yet recruiting
- Hepatic Artery Thrombosis
- +2 more
- Ticagrelor Oral Tablet [Brilinta]
- Low molecular weight heparin
-
Shanghai, ChinaRen Ji Hospital, School of Medicine, Shanghai Jiao Tong Universi
Jun 23, 2021
Acute Coronary Syndrome Trial in Montreal (Ticagrelor 90mg, Clopidogrel 75mg, acetylsalicylic acid (ASA) 81mg)
Active, not recruiting
- Acute Coronary Syndrome
- Ticagrelor 90mg
- +2 more
-
Montreal, Quebec, CanadaMcGill University Health Centre
Apr 14, 2021